Clinical Trial

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Name: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis — clinical trial record (NCT07171983)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-16

Trial Details

NCT Number	NCT07171983
Lead Sponsor	Bristol-Myers Squibb
Conditions	Rheumatoid Arthritis
Enrollment	46 participants
Start Date	2026-02-27
Primary Completion	2027-06-28 (estimated)
Study Completion	2027-08-25 (estimated)
Updated on ClinicalTrials.gov	2026-07-20